Archford Capital Strategies, LLC GNOM — GLOBAL X GENOMICS & BIOTECHNOLOGY ETF

Ownership history in Archford Capital Strategies, LLC  ·  17 quarters on record

AI Ownership Summary

Archford Capital Strategies, LLC reported GLOBAL X GENOMICS & BIOTECHNOLOGY ETF (GNOM) in 17 quarterly 13F filings from 2024 Q2 through 2025 Q4. Peak portfolio weight reached 0.06% in 2024 Q2. The latest visible filing shows GNOM at 0.03% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this GNOM ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Archford Capital Strategies, LLC's position in GLOBAL X GENOMICS & BIOTECHNOLOGY ETF, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

GNOM was reported at 0.03% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.06% in 2024 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Archford Capital Strategies, LLC held GNOM — position size vs. price
% of Fund (quarterly)    GNOM price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED — — — 6,187 +104 +1.7% 0.03% $281K 2026-01-15 $47.80
2025 Q3 REDUCED 77.7% +20.2% ❌ 6,083 -21,216 -77.7% 0.03% $236K 2025-10-17 $42.13
2025 Q2 REDUCED 18.2% +13.7% ❌ 27,299 -6,089 -18.2% 0.03% $230K 2025-07-17 $34.41
2025 Q1 REDUCED — — — 33,388 -74 -0.2% 0.04% $265K 2025-04-23 $31.85
2024 Q4 REDUCED 5.8% -18.1% ✅ 33,462 -2,070 -5.8% 0.05% $325K 2025-01-21 $39.32
2024 Q3 REDUCED — — — 35,532 -1,339 -3.6% 0.06% $395K 2024-10-15 $43.28
2024 Q2 ADDED — — — 36,871 +13,703 +59.1% 0.06% $385K 2024-07-17 $45.72
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Archford Capital Strategies, LLC and GNOM

These are the practical questions this page is built to answer before you even open the full history table.

How long has Archford Capital Strategies, LLC reported owning GNOM?

Archford Capital Strategies, LLC reported GNOM across 7 quarterly 13F filings, from 2024 Q2 through 2025 Q4.

What was the largest reported GNOM position in Archford Capital Strategies, LLC's portfolio?

The largest reported portfolio weight for GNOM was 0.06% in 2024 Q2.

What is the latest reported GNOM position on this page?

The most recent filing on this page is 2025 Q4, when Archford Capital Strategies, LLC reported 6,187 shares, equal to 0.03% of portfolio, with an estimated market value of $281K.

What does the chart on this GNOM ownership page compare?

The chart compares Archford Capital Strategies, LLC's quarterly GNOM portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Archford Capital Strategies, LLC time their GNOM position?

Based on 13F filing dates vs. subsequent GNOM price moves, Archford Capital Strategies, LLC correctly timed 5 out of 16 reported position changes (31%). The annualised alpha on GNOM relative to SPY over the holding period was -17.5%.

← Back to Archford Capital Strategies, LLC Holdings